DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME8N7L0

Market Closed - Börse Stuttgart 19:12:30 31/05/2024 BST
209.9 EUR +1.52% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-2.28%
1 month-2.28%
Date Price Change
31/05/24 209.9 +1.52%
30/05/24 206.8 -0.11%
29/05/24 207 -0.70%
28/05/24 208.4 -0.10%
27/05/24 208.6 +0.06%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 07:12 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME8N7L
ISINDE000ME8N7L0
Date issued 13/02/2024
Maturity 20/09/2024 (112 Days)
Parity 1 : 1
Emission price 219.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 220.6
Lowest since issue 204.1
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus